Cargando…
NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3
DDX3X (DDX3), a human RNA helicase, is over expressed in multiple breast cancer cell lines and its expression levels are directly correlated to cellular aggressiveness. NZ51, a ring-expanded nucleoside analogue (REN) has been reported to inhibit the ATP dependent helicase activity of DDX3. Molecular...
Autores principales: | Xie, Min, Vesuna, Farhad, Botlagunta, Mahendran, Bol, Guus Martinus, Irving, Ashley, Bergman, Yehudit, Hosmane, Ramachandra S., Kato, Yoshinori, Winnard, Paul T., Raman, Venu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745771/ https://www.ncbi.nlm.nih.gov/pubmed/26337079 |
Ejemplares similares
-
Expression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells
por: Botlagunta, Mahendran, et al.
Publicado: (2011) -
Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation
por: Kerr, Candace L., et al.
Publicado: (2019) -
RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2
por: Vesuna, Farhad, et al.
Publicado: (2022) -
DDX3, a potential target for cancer treatment
por: Bol, Guus Martinus, et al.
Publicado: (2015) -
Role of DDX3 in the pathogenesis of inflammatory bowel disease
por: Tantravedi, Saritha, et al.
Publicado: (2017)